Literature DB >> 32267462

Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting to Treat Ischemic Cardiomyopathy?

Eric J Velazquez1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32267462     DOI： 10.1001/jamacardio.2020.0597

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  2 in total

1.  Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.

Authors:  Derek S Chew; Patricia A Cowper; Hussein Al-Khalidi; Kevin J Anstrom; Melanie R Daniels; Linda Davidson-Ray; Yanhong Li; Robert E Michler; Julio A Panza; Ileana L Piña; Jean L Rouleau; Eric J Velazquez; Daniel B Mark
Journal:  Circulation       Date:  2022-01-19       Impact factor: 29.690

2.  Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery.

Authors:  Shaoping Wang; Yi Lyu; Shujuan Cheng; Jinghua Liu; Bijan J Borah
Journal:  Ther Clin Risk Manag       Date:  2021-10-15       Impact factor: 2.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.